Industry Overview

Asia-Pacific medical robotics market was valued at $4.90 billion in 2025 and is projected to reach $24.02 billion by 2035, growing at a CAGR of 17.3% during the forecast period (2026–2035). The Asia-Pacific medical robotics industry is set to expand steadily through 2026–2035 as healthcare providers adopt advanced automation to improve precision, efficiency, and patient outcomes. Hospitals across the Asia-Pacific region are increasingly integrating robotic platforms to address rising surgical volumes and workforce pressures. Demand is also being strengthened by improvements in system accuracy, enhanced imaging capabilities, and greater clinical confidence in robotic procedures. Growing investments from both private and public sectors are supporting wider deployment and technological upgrades. As healthcare systems modernize, robotics is becoming a central component of long-term digital transformation strategies. Together, these factors are creating a sustained growth path for the market over the forecast horizon.

Market Dynamics

Rising Integration of Robotics in Clinical Workflows

The Asia-Pacific market is witnessing broader adoption of robotic platforms as hospitals prioritize accuracy, consistency, and reduced procedure time. Enhanced imaging, improved motion control, and better surgeon–robot interfaces are accelerating acceptance across surgical and rehabilitative applications. As clinical teams become more familiar with these technologies, robotics is increasingly embedded into standard care pathways, supporting better patient outcomes and operational efficiency.

Increasing Investments in Advanced Healthcare Automation

Governments, private hospitals, and technology developers are allocating larger budgets to modernize healthcare infrastructure, driving demand for next-generation robotic systems. Funding is directed toward expanding minimally invasive capabilities, improving safety features, and developing specialized robots for high-complexity procedures. This steady flow of investment is reinforcing market growth, encouraging innovation, and strengthening the Asia-Pacific shift toward technology-driven medical care.

Market Segmentation

• Based on the product, the market is segmented into surgical robotic systems, rehabilitative robotic systems, noninvasive radiosurgery robots, hospital & pharmacy robotic systems, and others.

Surgical Robotic Systems Segment to Lead the Market with the Largest Share

Surgical robotics continues to gain popularity as hospitals look for greater precision and consistency in complex procedures. The market growth is being supported by factors such as expanding clinical evidence, rising surgeon training programs, and broader availability of compact robotic units. Companies such as Intuitive Surgical, Medtronic, and CMR Surgical are strengthening their presence through new system launches and regional partnerships. Recent trends include multi-port flexibility, improved haptic feedback, and the integration of real-time imaging into console workflows. These developments are helping drive wider adoption across tertiary care and specialty centers.

Rehabilitative Robotics: A Key Segment in Market Growth

Rehabilitative robotic systems are experiencing steady uptake as care providers seek more structured and measurable recovery pathways for patients. The segment is benefiting from rising demand for post-stroke therapy, musculoskeletal rehabilitation, and aging-related mobility support. Key market players such as Hocoma, Fourier Intelligence, and Ekso Bionics are introducing devices with greater adaptability and data-driven treatment features. Current trends point toward wearable exoskeletons, AI-assisted motion tracking, and cloud-based progress monitoring. Together, these enhancements are making robotic rehabilitation more accessible and clinically valuable across diverse therapy environments.

Regional Outlook

The Asia-Pacific medical robotics market is further divided by countries, including China, Japan, South Korea, India, Australia & New Zealand, ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and others), and the Rest of Asia-Pacific.

China Dominates the Market with a Major Share

China will remain the largest market due to its rapid hospital expansion, strong government incentives for high-end medical equipment, and a fast-growing domestic robotics industry. Companies such as MicroPort, Shinva, Tinavi, and Fourier Intelligence are scaling production and gaining regulatory approvals, while Asia-Pacific leaders such as Intuitive Surgical and Medtronic continue to expand partnerships with top-tier hospitals. High surgical volumes, increasing adoption of minimally invasive procedures, and rising demand for affordable robotic systems make China the region’s core growth engine.

Market Players Outlook

The major companies operating in the Asia-Pacific medical robotics market include Intuitive Surgical Operations Inc., Ekso Bionics Holdings Inc., Medtronic Inc., EndoMaster Pte Ltd., Zimmer Biomet Holdings Inc., Shanghai Fourier Intelligent Technology Co. Ltd., CMR Surgical Ltd., and Smith & Nephew Plc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In September 2025, HMI Medical to offer in ASEAN to offer robotic-assisted surgical procedures using hinotori at both its flagship hospitals – Mahkota Medical Centre (MMC) in Malacca and Regency Specialist Hospital (RSH) in Johor. Made possible by Kawasaki Heavy Industry‘s robot technology cultivated for over 50 years and Sysmex Corporation’s network and knowledge in the healthcare field, hinotori was developed as a robotic-assisted surgery (RAS) system to reproduce a surgeon's sensitive movement, which is essential for surgeries.

• In July 2025, Intuitive Surgical announced its da Vinci 5 robot received CE mark approval for adult and pediatric use in Europe across multiple minimally invasive procedures, including urologic, gynecologic, and general laparoscopic.

• In February 2024, CMR Surgical announced the launch of vLimeLite, an integrated fluorescence imaging system to visualize ICG (Indocyanine green), which will give surgeons enhanced visualization, where indicated. Versius Plus becomes the first CE-marked surgical robot on the market to offer an integrated ICG system with multiple viewing modes and color displays to visualize ICG, enhancing visualization during surgery.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the Asia-Pacific medical robotics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.